Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (MAGMA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01276678|
Recruitment Status : Unknown
Verified November 2013 by Kevin Bliden, LifeBridge Health.
Recruitment status was: Recruiting
First Posted : January 13, 2011
Last Update Posted : November 6, 2013
Information provided by (Responsible Party):
Kevin Bliden, LifeBridge Health
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||June 2014|
|Estimated Study Completion Date :||December 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Bliden KP, Singla A, Gesheff MG, Toth PP, Tabrizchi A, Ens G, Guyer K, Singh M, Franzese CJ, Stapleton D, Tantry US, Gurbel PA. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin. Thromb Haemost. 2014 Aug;112(2):323-31. doi: 10.1160/TH14-01-0094. Epub 2014 Apr 24.